| 项目编号 |
PRJCA021467 |
| 项目标题 |
Neoadjuvant gemcitabine/cisplatin plus tislelizumab in resectable muscle-invasive bladder cancer (BGB-A317-2002) |
| 涉及领域 |
Medical |
| 数据类型 |
Exome
Transcriptome or Gene expression
Genome sequencing
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
To further evaluate the role of Gemcitabine and cisplatin plus anti-PD-1 as neoadjuvant treatment for MIBC, we designed a phase 2 trial integrating (1) cisplatin-based chemotherapy plus tislelizumab; and (2) biomarkers to refine future patient selection for this approach. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-08-02 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China (NSFC)
|
|
NA
|
|
|
|
| 项目相关网站链接 |
| 项目相关网站链接 |
网站信息描述 |
| https://www.chictr.org.cn/ |
This clinical trial is registered at https://www.chictr.org.cn/ Registration number: CTR2000037670 |
|
|
| 提交者 |
Kaiwen
Li (likw6@mail.sysu.edu.cn)
|
| 提交单位 |
Sun Yat-sen Memorial Hospital, Sun Yat-sen University |
| 提交日期 |
2023-11-21 |
